Your shopping cart is currently empty

Patamostat mesylate (E-3123) is a potent protease inhibitor with IC50 values of 39 nM for trypsin, 950 nM for plasmin, and 1.9 μM for thrombin. This compound demonstrates promising potential in suppressing the pathogenesis and development of acute pancreatitis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $238 | In Stock | In Stock | |
| 5 mg | $582 | In Stock | In Stock | |
| 10 mg | $773 | In Stock | In Stock | |
| 25 mg | $1,170 | In Stock | In Stock |
| Description | Patamostat mesylate (E-3123) is a potent protease inhibitor with IC50 values of 39 nM for trypsin, 950 nM for plasmin, and 1.9 μM for thrombin. This compound demonstrates promising potential in suppressing the pathogenesis and development of acute pancreatitis. |
| Targets&IC50 | thrombin:1.9 μM, plasmin:950 nM, trypsin:39 nM |
| In vivo | In male Wistar rats weighing approximately 350 g, Patamostat mesylate (2 mg/kg; continuous intravenous infusion for 1 hour) significantly improved the survival rate[2]. |
| Synonyms | E-3123 mesylate, E3123 mesylate, E 3123 mesylate |
| Molecular Weight | 508.57 |
| Formula | C21H24N4O7S2 |
| Cas No. | 114568-32-0 |
| Smiles | O=C(OC1=CC=C(SCCN2C(=O)CCC2=O)C=C1)C3=CC=C(C=C3)NC(=N)N.O=S(=O)(O)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.